Patents by Inventor Ken Chi Lik Lee

Ken Chi Lik Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
    Patent number: 9266882
    Abstract: The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to imidazo[1,2-a]pyridine containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities (HDAC).
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: February 23, 2016
    Assignee: MEI PHARMA, INC.
    Inventors: Ken Chi Lik Lee, Eric T. Sun, Haishan Wang
  • IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS
    Publication number: 20150038703
    Abstract: The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to imidazo[1,2-a]pyridine containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities (HDAC).
    Type: Application
    Filed: October 17, 2014
    Publication date: February 5, 2015
    Inventors: Ken Chi Lik Lee, Eric T. Sun, Haishan Wang
  • Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
    Patent number: 8901149
    Abstract: The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to imidazo[1,2-a]pyridine containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities (HDAC).
    Type: Grant
    Filed: January 3, 2014
    Date of Patent: December 2, 2014
    Assignee: MEI Pharma, Inc.
    Inventors: Ken Chi Lik Lee, Eric T. Sun, Haishan Wang
  • IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS
    Publication number: 20140121203
    Abstract: The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to imidazo[1,2-a]pyridine containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities (HDAC).
    Type: Application
    Filed: January 3, 2014
    Publication date: May 1, 2014
    Applicant: MEI Pharma, Inc.
    Inventors: Ken Chi Lik Lee, Eric T. Sun, Haishan Wang
  • Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
    Patent number: 8648092
    Abstract: The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to imidazo[1,2-a]pyridine containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities (HDAC).
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: February 11, 2014
    Assignee: MEI Pharma
    Inventors: Ken Chi Lik Lee, Eric T. Sun, Haishan Wang